(Total Views: 520)
Posted On: 08/28/2024 3:35:50 PM
Post# of 155138
I am not sure if you remember Progenics Pharmaceuticals. We bought Leronlimab from them, but they merged with Lantheus Holdings, and today, the stock is worth $109.60 a share. I think PGNX was like $7.00 a share at the time.
Progenics, which previously traded on the Nasdaq market under the ticker PGNX, is being delisted, while the merged companies will continue to trade on the Nasdaq under Lantheus' LNTH ticker.
Now, what if they had kept Leronlimab? What would it be worth today?
I still own my shares. In 2012, they were about $1.20. I remember when Progenics sold to Cytodyn because they did not want to be in the HIV or Cancer business. I hope I do not want to wait another 12 years!
Guys, I am getting tired and old!
Progenics, which previously traded on the Nasdaq market under the ticker PGNX, is being delisted, while the merged companies will continue to trade on the Nasdaq under Lantheus' LNTH ticker.
Now, what if they had kept Leronlimab? What would it be worth today?
I still own my shares. In 2012, they were about $1.20. I remember when Progenics sold to Cytodyn because they did not want to be in the HIV or Cancer business. I hope I do not want to wait another 12 years!
Guys, I am getting tired and old!
(16)
(0)
